Increased NPC1L1 and serum cholesterol in a chronic rejection rat

被引:1
|
作者
Zhu, Yanfei [1 ]
Zhou, Jing [2 ]
机构
[1] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gen Surg, Wuxi 214023, Jiangsu Provinc, Peoples R China
[2] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pathol, Wuxi 214023, Jiangsu Provinc, Peoples R China
来源
CLINICAL AND INVESTIGATIVE MEDICINE | 2011年 / 34卷 / 03期
基金
中国国家自然科学基金;
关键词
CARDIAC TRANSPLANT RECIPIENTS; SMALL-INTESTINE TRANSPLANTATION; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; EZETIMIBE; HYPERLIPIDEMIA; ABSORPTION; ATHEROSCLEROSIS; THERAPY; PROTEIN;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: To measure serum cholesterol and triglyceride levels and NPC1L1 mRNA and protein as an index of cholesterol absorption during the development of chronic rejection (CR) in a rat model of intestinal transplantation. Methods: Rats were randomly divided into two groups: Group 1 (n=20) underwent syngenic Lewis-to-Lewis transplantation and Group 2 (n=20) underwent allogenic F344-to-Lewis transplantation as well as treatment with FK506. Blood samples and intestinal tissue were procured on the 190th day after operation. Histological changes were analyzed and the semiquantitative scores of histological parameters were compared. The serum levels of cholesterol and triglyceride were determined. The expression of Niemann-Pick C1 Like 1(NPC1L1) mRNA and protein were analyzed by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and immunohistochemistry, respectively. Results: All the animals survived for the 190 days. The appearance and histology of isografts were almost normal whereas the allografts displayed thickened bowel wall and mesenteric fibrosis, concentric intimal thickening and interstitial fibrosis and inflammatory in filtration. The histology scores displayed a significant difference between the allografts and isografts (P<0.001). No differences were observed for triglycerides for the two groups. The serum cholesterol levels increased significantly in the allogenic group in comparison with the syngenic group (P=0.034), while no difference was observed for triglyceride levels between groups. RT-PCR showed that the expression of NPC1L1 of allografts increased significantly (P=0.004). Immunohistochemistry confirmed RT-PCR findings. Conclusions: Neointima formation and mesenteric fibrosis were the dominant pathological features. The increased expression of NPC1L1 might contribute to hypercholesterolemia, which may be involved in the pathogenesis of transplant arteriosclerosis.
引用
收藏
页码:E172 / E178
页数:7
相关论文
共 50 条
  • [21] HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1
    Yuki Iwayanagi
    Tappei Takada
    Hiroshi Suzuki
    Pharmaceutical Research, 2008, 25 : 1134 - 1141
  • [22] Regulation of intestinal cholesterol absorption: the leading role of NPC1L1 and its functional polymorphisms
    Garces, Carmen
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 207 - 209
  • [23] Mutations in NPC1L1 and Coronary Heart Disease
    Mirshahi, Uyenlinh L.
    Carey, David J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09): : 881 - 881
  • [24] Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease
    Lauridsen, Bo Kobbero
    Stender, Stefan
    Frikke-Schmidt, Ruth
    Nordestgaard, Borge G.
    Tybjaerg-Hansen, Anne
    EUROPEAN HEART JOURNAL, 2015, 36 (25) : 1601 - 1608
  • [25] Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis
    Johnson, Tory A.
    Pfeffer, Suzanne R.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27 (11) : 1845 - 1852
  • [26] VARIATION IN HMGCR AND NPC1L1 AND INFLAMMATORY BIOMARKERS
    Li, Jiawen
    Tang, Xiao-Fang
    Xu, Jingjing
    Liu, Ru
    Li, Yulong
    Song, Lei
    Yuan, Jinqing
    Zhao, Xueyan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1012 - 1012
  • [27] FUNCTIONAL ANALYSIS OF THE NPC1L1 GENE PROMOTER
    Martin, Beatriz
    Solanas, Maria
    Pampin, Sandra
    Rodriguez-Rey, Jose-Carlos
    Civeira, Fernando
    Pocovi, Miguel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 183 - 189
  • [28] NPC1L1 mutations lower CHD risk
    Tim Geach
    Nature Reviews Cardiology, 2015, 12 (1) : 3 - 3
  • [29] Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling
    Xiao, Jian
    Dong, Le-Wei
    Liu, Shuai
    Meng, Fan-Hua
    Xie, Chang
    Lu, Xiao-Yi
    Zhang, Weiping J.
    Luo, Jie
    Song, Bao-Liang
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [30] Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling
    Jian Xiao
    Le-Wei Dong
    Shuai Liu
    Fan-Hua Meng
    Chang Xie
    Xiao-Yi Lu
    Weiping J. Zhang
    Jie Luo
    Bao-Liang Song
    Nature Communications, 14